Enhancing preclinical drug discovery with artificial intelligence
Author:
Funder
Pfizer
Wayne State University
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference154 articles.
1. Research and development costs of new drugs–reply;Wouters;JAMA,2020
2. 2020 FDA drug approvals;Mullard;Nat Rev Drug Discov,2021
3. A decade of FDA-approved drugs (2010–2019): trends and future directions;Brown;J Med Chem,2021
4. How artificial intelligence is changing drug discovery;Fleming;Nature,2018
5. Rethinking drug design in the artificial intelligence era;Schneider;Nat Rev Drug Discov,2020
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Potential of Artificial Intelligence to Accelerate Drug Development for Rare Diseases;Pharmaceutical Medicine;2024-02-05
2. Prophylactic and therapeutic measures for emerging and re-emerging viruses: artificial intelligence and machine learning - the key to a promising future;Health and Technology;2024-01-24
3. Techniques and Strategies in Drug Design and Discovery;International Journal of Molecular Sciences;2024-01-23
4. Machine learning approaches for the identification of ligands of the autophagy marker LC3;Artificial Intelligence Chemistry;2023-12
5. VGAE-MCTS: A New Molecular Generative Model Combining the Variational Graph Auto-Encoder and Monte Carlo Tree Search;Journal of Chemical Information and Modeling;2023-11-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3